| Dr Anu Singhal, MD | |
|
1812 Verdugo Blvd, Glendale, CA 91208-1407 | |
| (818) 790-7100 | |
| (818) 952-4618 |
| Full Name | Dr Anu Singhal |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 1812 Verdugo Blvd, Glendale, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144419961 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | A90963 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Saint Joseph Medical Ctr | Burbank, CA | Hospital |
| Providence Holy Cross Medical Center | Mission hills, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Buena Vista Anesthesia Medical Group | 7113975996 | 48 |
News Archive
Many patients with Parkinson's Disease (PD) develop mild cognitive impairment (MCI) or dementia. Identifying biomarkers for cognitive impairment could be instrumental in facilitating both early diagnosis of MCI and developing new cognitive-enhancing treatments. New research published in the Journal of Parkinson's Disease indicates that lower concentrations of α-synuclein in cerebrospinal fluid (CSF) is associated with reduced performance on several cognitive tests.
A 14 year old girl in United Kingdom around three decades back took a hit in the eye while playing badminton. She then lost her contact lens which was never found. After 28 years, the doctors have found the lens – it was embedded in a cyst in the inner wall of her left eyelid!
Results from the LESSON I trial presented today provide preliminary evidence for the therapeutic benefit of the newer generation everolimus-eluting stent over the previous gold standard, the early generation sirolimus-eluting stent. Moreover, LESSON I provides evidence that the formation of blood clots (stent thrombosis) - the principal shortcoming of early generation drug-eluting stents - may be diminished with the newer generation everolimus-eluting stent.
Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.
› Verified 2 days ago
| Entity Name | Buena Vista Anesthesia Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366462293 PECOS PAC ID: 7113975996 Enrollment ID: O20050107000780 |
News Archive
Many patients with Parkinson's Disease (PD) develop mild cognitive impairment (MCI) or dementia. Identifying biomarkers for cognitive impairment could be instrumental in facilitating both early diagnosis of MCI and developing new cognitive-enhancing treatments. New research published in the Journal of Parkinson's Disease indicates that lower concentrations of α-synuclein in cerebrospinal fluid (CSF) is associated with reduced performance on several cognitive tests.
A 14 year old girl in United Kingdom around three decades back took a hit in the eye while playing badminton. She then lost her contact lens which was never found. After 28 years, the doctors have found the lens – it was embedded in a cyst in the inner wall of her left eyelid!
Results from the LESSON I trial presented today provide preliminary evidence for the therapeutic benefit of the newer generation everolimus-eluting stent over the previous gold standard, the early generation sirolimus-eluting stent. Moreover, LESSON I provides evidence that the formation of blood clots (stent thrombosis) - the principal shortcoming of early generation drug-eluting stents - may be diminished with the newer generation everolimus-eluting stent.
Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anu Singhal, MD 225 S Lake Ave Ste 535, Pasadena, CA 91101-3010 Ph: (626) 795-6596 | Dr Anu Singhal, MD 1812 Verdugo Blvd, Glendale, CA 91208-1407 Ph: (818) 790-7100 |
News Archive
Many patients with Parkinson's Disease (PD) develop mild cognitive impairment (MCI) or dementia. Identifying biomarkers for cognitive impairment could be instrumental in facilitating both early diagnosis of MCI and developing new cognitive-enhancing treatments. New research published in the Journal of Parkinson's Disease indicates that lower concentrations of α-synuclein in cerebrospinal fluid (CSF) is associated with reduced performance on several cognitive tests.
A 14 year old girl in United Kingdom around three decades back took a hit in the eye while playing badminton. She then lost her contact lens which was never found. After 28 years, the doctors have found the lens – it was embedded in a cyst in the inner wall of her left eyelid!
Results from the LESSON I trial presented today provide preliminary evidence for the therapeutic benefit of the newer generation everolimus-eluting stent over the previous gold standard, the early generation sirolimus-eluting stent. Moreover, LESSON I provides evidence that the formation of blood clots (stent thrombosis) - the principal shortcoming of early generation drug-eluting stents - may be diminished with the newer generation everolimus-eluting stent.
Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.
› Verified 2 days ago
Mrs. Asmik Akopyan, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1030 S. Glendale Ave., Suite 404, Glendale, CA 91205 Phone: 818-240-9911 Fax: 818-240-9939 | |
Michael S Winston, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 824 N Glendale Ave, Glendale, CA 91206 Phone: 818-500-0523 | |
Dwight E Hiscox, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-550-0900 Fax: 505-293-1524 | |
Yukiko Ree, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1812 Verdugo Blvd, Glendale, CA 91208 Phone: 818-790-7100 | |
Arthur Victor Liu, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 Fax: 818-546-5632 | |
Varner Edward Dudley Iii, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 Fax: 818-546-5632 | |
Ivan Hronek, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1420 S Central Ave, Glendale, CA 91204 Phone: 818-502-1900 Fax: 818-502-4738 |